bioRxiv · 10.1101/2023.11.15.567251
Engineering self-deliverable ribonucleoproteins for genome editing in the brain
Abstract
The delivery of CRISPR ribonucleoproteins (RNPs) for genome editing in vitro and in vivo has important advantages over other delivery methods, including reduced off-target and immunogenic effects1. However, effective delivery of RNPs remains challenging in certain cell types due to low efficiency and cell toxicity. To address these issues, we engineered self-deliverable RNPs that can promote efficient cellular uptake and carry out robust genome editing without the need for helper materials or biomolecules. Screening of cell-penetrating peptides (CPPs) fused to CRISPR-Cas9 protein identified potent constructs capable of efficient genome editing of neural progenitor cells. Further engineering of these fusion proteins identified a C-terminal Cas9 fusion with three copies of A22p, a peptide derived from human semaphorin-3a, that exhibited substantially improved editing efficacy compared to other constructs. We found that self-deliverable Cas9 RNPs generated robust genome edits in clinically relevant genes when injected directly into the mouse striatum. Overall, self-deliverable Cas9 proteins provide a facile and effective platform for genome editing in vitro and in vivo.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Chen, K., Stahl, E. C., Kang, M. H., Xu, B., Allen, R., Trinidad, M., Doudna, J. A.. 2023-11-15. Engineering self-deliverable ribonucleoproteins for genome editing in the brain. https://doi.org/10.1101/2023.11.15.567251
Cite the original work for its findings. Save a collection to share your selection of sources.